CapsoVision, Inc Operating Cash Flow
CapsoVision, Inc (CV) reported Operating Cash Flow of -$14.47 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-13
- CapsoVision, Inc net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$8.40M.
- CapsoVision, Inc net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$6.07M.
- CapsoVision, Inc net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$7.69M.
- CapsoVision, Inc net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$5.67M.
- CapsoVision, Inc net cash provided by (used in) operating activities for fiscal 2025 was -$22.86M.
- CapsoVision, Inc net cash provided by (used in) operating activities for fiscal 2024 was -$20.09M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$8.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$14.47M 10-Q · filed 2026-08-13 | -$22.16M derived: sum of 3 quarters · filed 2026-08-13 | -$27.82M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | -$6.07M 10-Q · filed 2026-05-14 | -$13.75M derived: sum of 2 quarters · filed 2026-05-14 | -$19.42M derived: sum of 3 quarters · filed 2026-05-14 | -$23.94M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | -$7.69M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | -$13.35M derived: sum of 2 quarters · filed 2026-03-26 | -$17.88M derived: sum of 3 quarters · filed 2026-08-13 | -$22.86M 10-K · filed 2026-03-26 |
| 2025-09-30 | -$5.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$10.19M derived: sum of 2 quarters · filed 2026-08-13 | -$15.18M 10-Q · filed 2025-11-13 | -$20.58M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | -$4.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$9.51M 10-Q · filed 2026-08-13 | -$14.91M derived: sum of 3 quarters · filed 2026-08-13 | -$21.97M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | -$4.99M 10-Q · filed 2026-05-14 | -$10.38M derived: sum of 2 quarters · filed 2026-05-14 | -$17.44M derived: sum of 3 quarters · filed 2026-05-14 | |
| 2024-12-31 | -$5.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | -$12.46M derived: sum of 2 quarters · filed 2026-03-26 | -$20.09M 10-K · filed 2026-03-26 | |
| 2024-09-30 | -$7.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$14.69M 10-Q · filed 2025-11-13 | ||
| 2024-06-30 | -$7.64M 10-Q · filed 2025-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B |